Malaria primer for clinicians in the United States

Southern Medical Journal

Volumn 98, Issue 12, 2005, Pages 1197-1204

  Bledsoe, Gregory H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotherapy; Human immunodeficiency virus; Malaria; Mosquito

Indexed keywords

ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; DIETHYLTOLUAMIDE; DOXYCYCLINE; FANSIDAR; INSECT REPELLENT; MEFLOQUINE; PRIMAQUINE; PRIMAQUINE DERIVATIVE; PRIMAQUINE PHOSPHATE; PROGUANIL; QUINIDINE; QUINIDINE GLUCONATE; QUININE; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; BED NET; CHEMOTHERAPY; CLINICAL FEATURE; DIAGNOSTIC VALUE; DRUG COST; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; ECG ABNORMALITY; EMPORIATRICS; HEMOLYSIS; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSECT BITE; LIFE CYCLE; MALARIA; MALARIA CONTROL; MENTAL INSTABILITY; MOSQUITO; PARASITE DEVELOPMENT; PARASITE TRANSMISSION; PHOTOSENSITIVITY; PHYSICIAN ATTITUDE; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX; PREGNANCY; PREVENTIVE MEDICINE; PSYCHOSIS; QRS COMPLEX; TOOTH DISCOLORATION; UNITED STATES; VIVID DREAM;

ADULT; ANIMALS; ANTIMALARIALS; CHILD; HUMANS; LIFE CYCLE STAGES; MALARIA; PLASMODIUM; PRIMARY HEALTH CARE; TRAVEL; UNITED STATES;

EID: 30344452578     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000189904.50838.eb     Document Type: Article

References (46)

1. Filler S, Causer LM, Newman RD, et al. Malaria surveillance: United States, 2001. MMWR Surveill Summ 2003;52:1-14.
2. Kyriacou DN, Spira AM, Talan DA, et al. Emergency department presentation and misdiagnosis of imported falciparum malaria. Ann Emerg Med 1996;27:696-699.
3. Suh KN, Kain KC, Keystone JS. Malaria. CMAJ 2004;170:1693-1702.
4. Jerrard DA, Broder JS, Hanna JR, et al. Malaria: a rising incidence in the United States. J Emerg Med 2002;23:23-33.
5. Local transmission of Plasmodium vivax malaria: Palm Beach County, Florida, 2003. MMWR Morb Mortal Wkly Rep 2003;52:908-911.
6. Multifocal autochthonous transmission of malaria: Florida, 2003. MMWR Morb Mortal Wkly Rep 2004;53:412-413.
7. Layton M, Parise ME, Campbell CC, et al. Mosquito-transmitted malaria in New York City, 1993. Lancet 1995;346:729-731.
8. Local transmission of Plasmodium vivax malaria: Virginia, 2002. MMWR Morb Mortal Wkly Rep 2002;51:921-923.
9. Maldonado YA, Nahlen BL, Roberto RR, et al. Transmission of Plasmodium vivax malaria in San Diego County, California, 1986. Am J Trop Med Hyg 1990;42:3-9.
10. Band JD. Malaria, in Emergency Medicine: A Comprehensive Study Guide, JE Tintinalli, GD Kelen, and JS Stapczynski, Editors. 2004, McGraw-Hill: New York. 953-958.
11. Daily JP, Waldron MA. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises: case 22-2003: a 22-year-old man with chills and fever after a stay in South America. N Engl J Med 2003;349:287-295.
12. Svenson JE, Gyorkos TW, MacLean JD. Diagnosis of malaria in the febrile traveler. Am J Trop Med Hyg 1995;53:518-521.
13. Hogh B, Clarke PD, Camus D, et al. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study: Malarone International Study Team. Lancet 2000;356:1888-1894.
14. McKeage K, Scott L. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria. Drugs 2003;63:597-623.
15. Chiodini PL. Non-microscopic methods for diagnosis of malaria. Lancet 1998;351:80-81.
16. Muehlberger N, Jelinek T, Schlipkoeter U, et al. Effectiveness of chemoprophylaxis and other determinants of malaria in travellers to Kenya. Trop Med Int Health 1998;3:357-363.
17. Malaria, in Control of Communicable Diseases Manual, J. Chin, Editor. 2000, American Public Health Association: Washington, DC.
18. Kain KC, Shanks GD, Keystone JS. Malaria chemoprophylaxis in the age of drug resistance, I: currently recommended drug regimens. Clin Infect Dis 2001;33:226-234.
19. Bradley DJ, Bannister B. Guidelines for malaria prevention in travellers from the United Kingdom for 2001. Commun Dis Public Health 2001;4:84-101.
20. Baird JK, Fryauff DJ, Hoffman SL. Primaquine for prevention of malaria in travelers. Clin Infect Dis 2003;37:1659-1667.
21. Reid AJ, Whitty CJ, Ayles HM, et al. Malaria at Christmas: risks of prophylaxis versus risks of malaria. BMJ 1998;317:1506-1508.
22. Arguin P, et al. Malaria, in Health Information for International Travel 2003-2004, PM Arguin, et al, Editors. 2003, US Department of Health and Human Services: Atlanta. 99-116.
23. Carson PE, et al. Enzymatic deficiency in primaquine-sensitive erythrocytes. Science 1956;124:484-485.
24. Illinois Department of Corrections Archives Unit, April 2003.
25. Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa. Lancet 1993;341:1299-1303.
26. Lobel HO, Miani M, Eng T, et al. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993;341:848-851.
27. Magill AJ. The prevention of malaria. Prim Care 2002;29:815-842.
28. Pukrittayakamee S, Chantra A, Vanijanonta S, et al. Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malaria. Antimicrob Agents Chemother 2000;44:2395-2398.
29. Humar A, Sharma S, Zoutman D, et al. Fatal falciparum malaria in Canadian travellers. CMAJ 1997;156:1165-1167.
30. Rosenthal PJ, Petersen C, Geertsma FR, et al. Availability of intravenous quinidine for falciparum malaria. N Engl J Med 1996;335:138.
31. Nosten F, Luxemburger C, ter Kuile FO, et al. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. J Infect Dis 1994;170:971-977.
32. Bledsoe GH. The West Nile virus: a lesson in emerging infections. Wilderness Environ Med 2004;15:113-118.
33. Foster WA, Lutes KI. Tests of ultrasonic emissions on mosquito attraction to hosts in a flight chamber. J Am Mosq Control Assoc 1985;1:199-202.
34. Fradin MS. Mosquitoes and mosquito repellents: a clinician's guide. Ann Intern Med 1998;128:931-940.
35. Fradin MS, Day JF. Comparative efficacy of insect repellents against mosquito bites. N Engl J Med 2002;347:13-18.
36. Govere J, Braack LE, Durrheim DN, et al. Repellent effects on Anopheles arabiensis biting humans in Kruger Park, South Africa. Med Vet Entomol 2001;15:287-292.
37. Heal JD, Surgeoner GA, Lindsay LR. Permethrin as a tent treatment for protection against field populations of Aedes mosquitoes. J Am Mosq Control Assoc 1995;11:99-102.
38. Graham K, Mohammad N, Rehman H, et al. Insecticide-treated plastic tarpaulins for control of malaria vectors in refugee camps. Med Vet Entomol 2002;16:404-408.
39. Schreck CE. Permethrin and dimethyl phthalate as tent fabric treatments against Aedes aegypti. J Am Mosq Control Assoc 1991;7:533-535.
40. Lillie TH, Schreck CE, Rahe AJ. Effectiveness of personal protection against mosquitoes in Alaska. J Med Entomol 1988;25:475-478.
41. Sholdt LL, Schreck CE, Qureshi A, et al. Field bioassays of permethrin-treated uniforms and a new extended duration repellent against mosquitoes in Pakistan. J Am Mosq Control Assoc 1988;4:233-236.
42. Bouma MJ, Parvez SD, Nesbit R, et al. Malaria control using permethrin applied to tents of nomadic Afghan refugees in northern Pakistan. Bull World Health Organ 1996;74:413-421.
43. Marchant T, Schellenberg JA, Edgar T, et al. Socially marketed insecticide-treated nets improve malaria and anaemia in pregnancy in southern Tanzania. Trop Med Int Health 2002;7:149-158.
44. Rowland M, Durrani N, Hewitt S, et al. Permethrin-treated chaddars and top-sheets: appropriate technology for protection against malaria in Afghanistan and other complex emergencies. Trans R Soc Trop Med Hyg 1999;93:465-472.
45. Abramowicz M. Advice for Travelers. Treatment Guidelines from The Medical Letter 2004;2:33-40.
46. Talalay P, Beutler E. The role of Charles Ickes in the Army Malaria Research Project (personal communication). 2003:Baltimore, Maryland.